Xcorporeal (OTCMKTS:XCRP) and Varian Medical Systems (NYSE:VAR) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, analyst recommendations, risk, earnings, institutional ownership, profitability and dividends.
Institutional and Insider Ownership
87.0% of Varian Medical Systems shares are owned by institutional investors. 0.8% of Varian Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Analyst Ratings
This is a breakdown of current recommendations for Xcorporeal and Varian Medical Systems, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Xcorporeal | 0 | 0 | 0 | 0 | N/A |
Varian Medical Systems | 3 | 5 | 0 | 0 | 1.63 |
Varian Medical Systems has a consensus target price of $159.3571, indicating a potential downside of 10.00%. Given Varian Medical Systems' higher probable upside, analysts clearly believe Varian Medical Systems is more favorable than Xcorporeal.
Risk and Volatility
Xcorporeal has a beta of 3.62, meaning that its stock price is 262% more volatile than the S&P 500. Comparatively, Varian Medical Systems has a beta of 1.06, meaning that its stock price is 6% more volatile than the S&P 500.
Profitability
This table compares Xcorporeal and Varian Medical Systems' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Xcorporeal | N/A | N/A | N/A |
Varian Medical Systems | 8.50% | 18.45% | 8.08% |
Earnings and Valuation
This table compares Xcorporeal and Varian Medical Systems' gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Xcorporeal | N/A | N/A | N/A | N/A | N/A |
Varian Medical Systems | $3.17 billion | 5.13 | $269.20 million | $3.91 | 45.29 |
Varian Medical Systems has higher revenue and earnings than Xcorporeal.
Summary
Varian Medical Systems beats Xcorporeal on 7 of the 8 factors compared between the two stocks.